Quarterly Focus Issue: Heart Rhythm DisordersState-of-the-Art PaperIndications for Implantable Cardioverter-Defibrillators Based on Evidence and Judgment
State-of-the-Art Paper
Under an Elsevier user license
open archive
Key Words
implantable cardioverter-defibrillators
indications
review
Abbreviations and Acronyms
CAD
coronary artery disease
CMS
Center for Medicare and Medicaid Services
EF
ejection fraction
HCM
hypertrophic cardiomyopathy
ICD
implantable cardioverter-defibrillator
MI
myocardial infarction
NYHA
New York Heart Association
PVC
premature ventricular complex
SCD
sudden cardiac death
VF
ventricular fibrillation
VT
ventricular tachycardia
Cited by (0)
Dr. Myerburg is supported in part by a grant from the Leducq Foundation (Network on Sudden Cardiac Death), by the Florida Heart Research Foundation, and by the American Heart Association Chair in Cardiovascular Research at the University of Miami Miller School of Medicine; he has also received consulting fees during the past 24 months from Boston Scientific Corporation, Proctor and Gamble, GlaxoSmithKline Pharmaceuticals, and Sanofi-Aventis, and lecture fees from Boston Scientific Corporation, General Electric Company, and St. Jude Medical Corporation. Dr. Reddy has received consulting fees and grants from St. Jude, and speaker honoraria from Medtronic and Boston Scientific.
Copyright © 2009 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.